Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients [NA]
A Columbia University-sponsored clinical trial evaluating Apricity CARE to improve immune checkpoint inhibitor outcomes in ethnically/racial…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations. [Phase 2]
Phase II trial of amivantamab plus single-agent chemotherapy in platinum-unfit NSCLC with EGFR exon 20 insertion is currently recruiting. Sp…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED) [Phase 2]
This entry reports a Phase 2 clinical trial evaluating Tedopi combined with either docetaxel or nivolumab as second-line therapy for metasta…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial [NA]
This clinical trial update describes the BOOST trial, which investigates whether exercise training can improve immune activity and treatment…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial is evaluating PBF-1129 in combination with nivolumab for recurrent or metastatic non-small cell lung cancer and is currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Study Investigating Anti-drug Antibodies in NSCLC Patients Exposed to Checkpoint Inhibitors (IMB)
A clinical trial update notes an ongoing study investigating anti-drug antibodies in non-small cell lung cancer patients treated with checkp…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Real-World Comparison of Chemo-Immunotherapy Regimens in Metastatic NSCLC With PD-L1 <50% (ALCG-01)
A real-world comparison of chemo-immunotherapy regimens for metastatic non-small cell lung cancer with PD-L1 <50% is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene [Phase 2]
Phase 2 study of AB-106 in advanced non-small cell lung cancer with ROS1 fusions is listed as active but not currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Phase II Study of SKB571 in Patients With Lung Cancer [Phase 2]
A Phase II clinical trial evaluating SKB571 in patients with non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy [Phase 2]
A Phase 2 clinical trial evaluating JS207 for advanced non-small cell lung cancer after progression on platinum-based chemotherapy and immun…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Pathological Response After Neoadjuvant Treatment on NSCLC
This clinical trial entry reports on pathological response after neoadjuvant treatment for stage IIIA non-small cell lung cancer and notes t…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen [Phase 1]
Phase 1 trial evaluating durvalumab with grid therapy for non-small cell lung cancer progressing during or after the PACIFIC regimen; the st…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC
A clinical trial to evaluate whether peripheral blood ETASTs can predict the efficacy of chemoimmunotherapy in non-small cell lung cancer. T…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Expanded Access to Telisotuzumab Vedotin
AbbVie has opened Expanded Access for Telisotuzumab Vedotin to patients with non-small cell lung cancer. The program status is AVAILABLE.
-
EMA approval · 2026-02-05EMA Authorised: Avzivi (bevacizumab) — FGK Representative Service GmbH
EMA authorised Avzivi (bevacizumab) for multiple indications including colorectal cancer, non-small cell lung cancer, renal cell carcinoma, …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer [Phase 3]
This clinical trial update describes a Phase 3 study evaluating SKB264 in combination with pembrolizumab versus chemotherapy with pembrolizu…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of SH009 Injection in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 clinical trial update for SH009 Injection in patients with advanced solid tumors, currently recruiting across multiple indications…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects
This clinical trial in metastatic non-small cell lung cancer is evaluating gut microbiome diversity and its correlation with cancer treatmen…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Brain Oligometastasis in NSCLC
Clinical trial update for a study on brain oligometastasis in non-small cell lung cancer shows the trial is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial is evaluating Zipalertinib in combination with carboplatin and pemetrexed for patients with resectable stage II-…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of MGC026 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for MGC026 in participants with advanced solid tumors; study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.
Clinical trial update on studying Lorlatinib in patients with metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
AstraZeneca is conducting a Phase 2 trial evaluating novel combinations for Non-Small Cell Lung Cancer, and the study is currently recruitin…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: GEMINI-NSCLC: NSCLC Biomarker Study
A clinical trial update for GEMINI-NSCLC, a biomarker study in non-small cell lung cancer sponsored by Tempus AI, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer [EARLY_Phase 1]
This document reports an early-stage Phase 1 trial at UNC evaluating autologous CAR T-cells targeting the GD2 antigen for lung cancer, with …